|
|
Volumn 333, Issue 6044, 2011, Pages 819-821
|
|
Trying to reset the clock on type 1 diabetes
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
AUTOANTIBODY;
C PEPTIDE;
GLUCOSE;
HEMOGLOBIN;
INSULIN;
INTERLEUKIN 1BETA;
MONOCLONAL ANTIBODY CD3;
RITUXIMAB;
CD3 ANTIGEN;
MONOCLONAL ANTIBODY;
DIABETES;
DISEASE TREATMENT;
DRUG DEVELOPMENT;
ETHICS;
HEALTH EXPENDITURE;
MEDICINE;
PHARMACEUTICAL INDUSTRY;
RESEARCH AND DEVELOPMENT;
SYMPTOM;
AUTOIMMUNE DISEASE;
CELL INFILTRATION;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
DRUG ERUPTION;
DRUG FEVER;
DRUG TARGETING;
DRUG TREATMENT FAILURE;
EFFECTOR CELL;
ENVIRONMENTAL FACTOR;
FATIGUE;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
INSULIN BLOOD LEVEL;
INSULIN DEPENDENT DIABETES MELLITUS;
MORBIDITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
REGULATORY T LYMPHOCYTE;
SHORT SURVEY;
T LYMPHOCYTE;
THIRST;
WEIGHT REDUCTION;
ANIMAL;
CLINICAL TRIAL (TOPIC);
IMMUNOLOGY;
MOUSE;
NOTE;
PATHOLOGY;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD3;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 1;
HUMANS;
INSULIN-SECRETING CELLS;
MICE;
T-LYMPHOCYTES;
|
|
EID: 80051650851
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.333.6044.819 Document Type: Short Survey |
|
Times cited : (22)
|
|
References (0)
|
